Cargando…

Interleukin receptor antagonist induction in kidney transplantation: Is it worth the price?

Detalles Bibliográficos
Autor principal:	Kher, V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841507/ https://www.ncbi.nlm.nih.gov/pubmed/24339517

Ejemplares similares

Physiologic role of interleukin-1 receptor antagonist
por: Arend, William P, et al.
Publicado: (2000)

Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study
por: Heldal, Kristian, et al.
Publicado: (2013)

The Promise of Specialty Pharmaceuticals: Are They Worth the Price?
por: Sullivan, Sean D.
Publicado: (2008)

OMICS-based personalized oncology: if it is worth doing, it is worth doing well!
por: Hayes, Daniel F
Publicado: (2013)

Pricing vaccines and drugs in Europe: worth differentiating?
por: Garattini, Livio, et al.
Publicado: (2020)

The cost-effectiveness challenge: is it worth it?
por: Knapp, Martin
Publicado: (2015)

Commentary: Is the juice worth the squeeze?
por: Demmy, Todd L.
Publicado: (2020)

Commentary: Is the juice worth the squeeze?
por: Lantz, Gurion, et al.
Publicado: (2021)

Global longitudinal strain in cardio-oncology: worth our trouble or more trouble than it’s worth?
por: Teske, Arco J.
Publicado: (2023)

Is sodium chloride worth its salt?
por: McIntosh, Euan, et al.
Publicado: (2013)

Lung biopsy in ARDS: is it worth the risk?
por: Malhotra, Atul, et al.
Publicado: (2006)

“TEG” talks: technology worth spreading?
por: Selby, Rita
Publicado: (2023)

Is Large Hadron Collider worth massive price tag?
Publicado: (2009)

Non-in situ heart-lung transplantation: doing less may prove to be worth it
por: Thomas, Jason O. A., et al.
Publicado: (2021)

Antimicrobial catheters in the ICU: is the juice worth the squeeze?
por: Safdar, Nasia
Publicado: (2009)

A Picture Is Worth a Thousand Words
por: Turner, Jerrold R.
Publicado: (2016)

A Budget in Hand is Worth Two in the Bush
Publicado: (2000)

Pharmaceutical Manufacturer Prescription Assistance Programs: Are They Worth It?
por: Chen, Judy T., et al.
Publicado: (2007)

Is the Large Hadron Collider worth its massive price tag?
Publicado: (2009)

Albumin in critical care: SAFE, but worth its salt?
por: Fan, Eddy, et al.
Publicado: (2004)

Stabilizing the Code—Methods to Preserve RNA Prove Their Worth
por: Williams, Marc A.
Publicado: (2010)

Debate: Are surrogate end-point studies worth the effort?
por: Valabhji, Jonathan, et al.
Publicado: (2000)

Commentary: An ounce of prevention is worth a pound of cure
por: Well, Andrew, et al.
Publicado: (2021)

Electronic hand hygiene monitoring systems: Not worth the costs
por: Doll, Michelle E., et al.
Publicado: (2022)

Optimizing twice weekly dialysis-converting two-star into five-star treatment?
por: Kher, A., et al.
Publicado: (2015)

An Ounce of Tat Prevention Is Worth a Pound of Functional Cure
por: Planelles, Vicente
Publicado: (2015)

Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study
por: Qiu, Jiang, et al.
Publicado: (2019)

What Is the Price Benchmark to Replace Average Wholesale Price (AWP)?
por: Curtiss, Frederic R.
Publicado: (2010)

Price and Prejudice? The Value of Chimeric Antigen Receptor (CAR) T-Cell Therapy
por: Choi, Gyeyoung, et al.
Publicado: (2022)

Fondaparinux in heparin‐induced thrombocytopenia: A decade's worth of clinical experience
por: Schindewolf, Marc
Publicado: (2018)

Higher medical training in Rheumatology in the UK: any lessons worth learning?
por: Hassell, Andrew
Publicado: (2017)

Commentary: Advanced Coats’ disease – Is it worth chasing the goal of globe salvage?
por: Singh, Simar R, et al.
Publicado: (2022)

Postvaccine Myocarditis: A Risk Worth the Reward?
por: Raman, Betty, et al.
Publicado: (2022)

For Whom the Price Escalates: High Price and Uncertain Value of Cancer Drugs
por: Shin, Gyeongseon, et al.
Publicado: (2022)

Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms
por: Pinkerton, JoAnn V, et al.
Publicado: (2023)

Hyponatremia: A role for vasopressin receptor antagonists?
por: Ramesh, Gourishankar
Publicado: (2018)

Value-based tiered pricing for universal health coverage: an idea worth revisiting
por: Chalkidou, Kalipso, et al.
Publicado: (2020)

Clinical features and outcome of vertebral osteomyelitis after spinal injection: is it worth the price?
por: Yagdiran, Ayla, et al.
Publicado: (2023)

Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases
por: Waldmann, Thomas A
Publicado: (2004)

Simultaneous appendage ligation and atrial ablation – is it worth the risk?
por: Garg, Jalaj, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mhk3s0pll477q48ai3imb6cgba